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Takayasu arteritis (TA) is a rare chronic vasculitis that affects 
the large-sized vessels, such as the aorta and its major branch-
es, coronary arteries, and pulmonary arteries. In 1908, the first 
case of TA was reported in a 21-year-old woman with retinal 
arteriovenous anastomoses and absence of pulse on the upper 
extremity.1 TA is currently classified based on the American Col-
lege of Rheumatology (ACR) 1990 criteria (1990 ACR criteria), 
which include the following six items: 1) age ≤40 years at dis-
ease onset, 2) claudication of the extremities, 3) decreased pul-
sation of one or both brachial arteries, 4) difference of at least 
10 mm Hg in systolic blood pressure between the arms, 5) bruit 
over one or both subclavian arteries or the abdominal aorta, and 
6) arteriographic narrowing or occlusion of the entire aorta, its 
primary branches or large arteries in the proximal upper or low-
er extremities, excluding arteriosclerosis, fibromuscular dys-
plasia, or other causes. If more than three of these six items are 
met, a patient can be classified as TA.2
TA often occurs in young women, and most patients are clas-
sified before the age of 40 years.3,4 Hence, concerns over preg-
nancy morbidities, which may be induced by either TA itself or 
medications for its treatment, or both in patients with TA of the 
childbearing age, have been raised. In clinical practice, preg-
nancy morbidities, such as spontaneous abortion, intrauterine 
growth restriction (IUGR), preeclampsia or eclampsia, gestation-
al diabetes mellitus (GDM), and preterm birth, have been report-
ed in patients with TA.5 However, it remains unclear whether 
the rate and severity of pregnancy morbidities in patients with 
TA are higher than that of the general population.6-8 Korea is one 
of the countries with the highest prevalence of TA worldwide.9 
However, to date, no study has evaluated pregnancy morbidi-
ties of TA in Korea. Therefore, we investigated pregnancy mor-
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bidities in the Korean patients with TA in a single tertiary hos-
pital as a pilot study. 
We retrospectively reviewed the medical records of 58 preg-
nancies in 37 patients with TA. We excluded 46 pregnancies 
due to lack of delivery data, such as gestational age. Finally, 12 
pregnancies in seven patients with TA were included in this 
study. All patients fulfilled the 1990 ACR criteria2 and were clas-
sified as TA at the Rheumatology Division of Yonsei University 
College of Medicine, Severance Hospital between January 1995 
and December 2017. The medical records of all patients were 
well-documented, allowing to collect and review clinical and 
laboratory data and medical histories, particularly pregnancy 
morbidities. This study was approved by the Institutional Re-
view Board (IRB) of Severance Hospital (4-2019-0699), and the 
need for written informed consent was waived by the approv-
ing IRB due to the retrospective nature of this study. 
The angiographic classification of TA was defined based on 
the new classification proposed by Hata, et al.10 in 1996: Type I 
involves branches from aortic arch; Type IIa involves ascend-
ing aorta, aortic arch, and its branches; Type IIb involves as-
cending aorta, aortic arch, and thoracic descending aorta; Type 
III affects thoracic aorta, abdominal aorta, and/or renal arter-
ies; Type IV affects only the abdominal aorta and/or renal ar-
teries; and Type V involves combined features. The Ishikawa’s11 
classification of TA was also applied to patients with TA based 
on Ishikawa’s severity criteria, which include the following three 
groups: Group 1 (patients with no complications), Group 2 (pa-
tients with one of following complications: Takayasu retinop-
athy, secondary hypertension, aortic regurgitation, or aortic or 
arterial aneurysm); Group 2 was subdivided into class 2a and 
2b by severity, and Group 3 (patients with two or more compli-
cations listed above).
Active disease was defined as a state with the new onset of 
two or more of the following features: 1) systemic features, such 
as fever or myalgia; 2) elevation of erythrocyte sedimentation 
rate or C-reactive protein level; 3) features of vascular ischemia 
or inflammation, such as claudication of extremities, diminished 
pulse, bruits, vascular pain, or asymmetric blood pressure; and 
4) new vascular lesion(s) on imaging studies.12 Stable disease 
was defined as a state without the abovementioned features. 
In this study, spontaneous abortion, therapeutic abortion, 
and fetal and maternal complications, such as preterm birth, 
IUGR, congenital anomaly, neonatal intensive care unit ad-
mission, preeclampsia or eclampsia, gestational hypertension, 
GDM, were considered as pregnancy morbidities.6
Continuous variables are presented as medians with inter-
quartile ranges, and categorical variables are presented as num-
bers with percentages. Statistical analyses were performed us-
ing the Statistical Package for the Social Sciences software 
version 25 for Windows (IBM Corp., Armonk, NY, USA). 
The median age at diagnosis of seven patients with TA was 
27.0 years, and that at the time of delivery of 12 pregnancies 
was 32.0 years. Initial presentation, arterial involvement, angi-
ographic and Ishikawa classification are shown in Table 1. The 
most frequently affected vessel was the common carotid artery 
(71.4%), followed by descending aorta (57.1%). All but one pa-
tients were diagnosed with TA before conception. All except 
one patient, who was diagnosed with TA after delivery, had sta-
ble disease activity at delivery. Glucocorticoids were maintained 
throughout the pregnancies in nine out of 12 cases with the 
daily dose within 10 mg per day (prednisolone equivalent). 
Immunosuppressive agents, such as azathioprine and metho-
trexate, were used in eight out of 12 cases before conception, 
Table 1. Disease Characteristics of 7 Patients at the Diagnosis of TA and 
12 Cases of Pregnancies
Variables Values
Seven patients with TA
Ages at diagnosis (yr) 27.0 (13.0)
Clinical features at diagnosis
Bruit (subclavian or aorta) 5 (71.4)
Blood pressure difference >10 mm Hg 4 (57.1)
Decreased brachial pulse 1 (14.3)
Claudication 0 (0)
Involved vessels at diagnosis
Common carotid artery 5 (71.4)
Descending aorta 4 (57.1)
Subclavian artery 2 (28.6)
Ascending aorta 2 (28.6)
Aortic arch 2 (28.6)
Abdominal aorta 2 (28.6)
Renal artery 2 (28.6)
Iliac artery 0 (0)
Pulmonary artery 1 (14.3)













Age of delivery 32.0 (12.0)
Maternal age >35 years at delivery 5 (41.7)
Assisted by reproductive technology 0 (0)
Previous abortion history 
Spontaneous abortion 2 (16.7)
Induced abortion 2 (16.7)
TA, Takayasu arteritis.
Values are expressed as a median (interquartile range) or n (%).
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but withheld while planning pregnancy.
Of the 12 pregnancies, nine neonates were delivered alive; 
two pregnancies ended in spontaneous abortion (16.7%) at 4 
and 9 weeks of gestation, and one pregnancy (8.3%) underwent 
therapeutic abortion at 9 weeks of gestation due to maternal 
morbidity (Table 2 and 3). No antiphospholipid-related anti-
bodies were detected in the patients experiencing spontane-
ous abortion. 
Of the nine live neonates, the median gestational age at de-
livery was 38 weeks, and the median birth weight was 3060 g. 
Among them, preterm birth before 37 weeks of gestation oc-
curred in one (11.1%). Three pregnancy morbidities occurred. 
One pregnancy developed GDM and preeclampsia, and the 
baby was born at 38 weeks of gestation with birth weight of 
2200 g due to IUGR. Another pregnancy developed GMD, but 
delivered normal weight baby. The other pregnancy resulted 
in premature labor, and underwent emergency caesarean sec-
tion at 30 weeks of gestation. That baby was born with birth 
weight of 1240 g. Only one child (11.1%) was delivered via nor-
mal spontaneous vaginal delivery, and the remaining eight 
(88.9%) were delivered by Caesarean section. 
Six out of 12 cases of pregnancy (50%) had underlying hyper-
tension before pregnancy, which was assumed to be related to 
TA. Among them, maternal blood pressure in one pregnancy 
was poorly controlled at delivery, but there were no maternal/
fetal complications.
Table 2. Pregnancy Outcome of TA
Pregnancy outcome Values
Total pregnancies 12
Live births 9 (75.0)
Gestational age at delivery (weeks) 38.0 (13.0)
C/sec 8 (88.9)
NSVD 1 (11.1)
Spontaneous abortion 2 (16.7)
Termination of pregnancy 1 (8.3)
Fetal outcome
Birth weight (g) 3060 (260)
Preterm birth <37 weeks gestation 1/9 (11.1)
Intrauterine fetal demise 0
Small for gestational age 1/9 (11.1)
Congenital anomaly 0 (0)
Fetal NICU admission 2 (16.7)
Neonatal death 0 (0)
Maternal complications
Preeclampsia 1 (8.3)
Gestational hypertension 0 (0)
Gestational diabetes 2 (16.7)
Pregestational diabetes 1 (8.3)
Thyroid diseases 0
TA, Takayasu arteritis; C/sec, Caesarean section; NSVD, normal spontaneous 
vaginal delivery; NICU, neonatal intensive care unit.
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Among the eight cases of Caesarean section, only one case 
was planned for the surgery due to disease of the circulatory sys-
tem associated with TA. Other indications for Caesarean sec-
tion included advanced maternal age (2/8), arrest of descent 
(1/8), minimal variability of fetal heart rate (1/8), prior cesarean 
section (1/8), and unknown (2/8). Table 3 shows pregnancy 
outcomes for each of the 12 pregnancies in seven patients with 
TA, and Table 4 summarizes previous published reports and 
compares data with the current data. 
To our knowledge, this is the first study to assess pregnancy 
morbidities in Korean patients with TA. In this study, successful 
delivery was observed in nine of 12 pregnancies (75.0%) in a to-
tal of seven patients with TA. Three pregnancies had pregnancy 
morbidity: one pregnancy had preeclampsia, GDM, and IUGR; 
the other had GDM; and the last one was born prematurely. 
Disease activity of TA remained stable at the time of delivery 
in all patients in our study. This observation was supported by 
a study demonstrating the influence of pregnancy on TA, which 
showed improving inflammatory markers during pregnancy 
in TA patients.13 Nonetheless, pregnancy morbidities were high-
er compared to the general population in Korea. We looked at 
the factors that caused this observation. First, we reviewed the 
angiographic classification. There were four pregnancies in 
angiographic classification Type I, three pregnancies in Type 
IIb, two pregnancies in Type III, and three pregnancies in Type 
V. Among pregnancies with Type I, two cases resulted in abor-
tion (either therapeutic or spontaneous); one pregnancy was 
complicated with GDM, preeclampsia, and IUGR; and the oth-
er pregnancy resulted in normal delivery without complication. 
Among pregnancies with Type IIb, one pregnancy resulted in 
preterm birth, and the other two pregnancies resulted in nor-
mal delivery. Two pregnancies with Type III ended without 
complication; and among two Type V pregnancies, one preg-
nancy ended in spontaneous abortion, but the other pregnan-
cy resulted in normal delivery. However, we could not conclude 
that Types I and V TA might be associated with pregnancy mor-
bidities due to the small number of pregnancies in this study. 
Furthermore, we had assumed that the risk of gestational hy-
pertension or preeclampsia may be theoretically increased in 
Types III, IV, and V TA, as renal arterial involvement in TA could 
increase the risk of renovascular hypertension; however, in 
our patients, preeclampsia was observed in only one patient 
with Type I TA. The absence of patients with Type IV TA made 
the interpretation of this association difficult. Second, the pos-
sibility of association between the Ishikawa classification of 
TA with pregnancy morbidities was assessed. There were two 
pregnancies with Ishikawa Type 1; one pregnancy ended in 
preterm birth, but the other resulted in normal delivery. There 
were nine pregnancies with Ishikawa classification Type 2a; 
and among them, three pregnancies ended in abortion (either 
therapeutic or spontaneous), and one pregnancy had pregnan-
cy morbidity (GDM, preeclampsia, and IUGR). Remaining five 
pregnancies with Type 2a resulted in normal delivery. One 
pregnancy with Type 3 was complicated with GDM, but deliv-
ered normal weight neonate. Therefore, although the clinical 
significance is not strong, we suggest that attention should be 
paid to patients with Types I and V and Ishikawa Groups 2 and 
3 TA. Lastly, the disease activity of TA remained stable at the 
time of delivery in all patients. This suggests two things. First, 
maintaining stable TA through proper steroid administration 
would not have resulted in serious complications, such as ma-
ternal death or TA aggravation. Second, the disease courses of 
TA, including established arterial stenosis or aneurysm, did 
not seem to directly affect pregnancy morbidities. Therefore, 
we suggest that physicians should not be negative for steroid 
use and should make efforts to maintain low TA activity dur-
ing pregnancy.
We searched for previous studies investigating the pregnan-















14 (2010) India After diagnosis 15 37 27.6 (4.7)* 25 (67.6)
GR (16.2), preterm birth (16.2),  
  preeclampsia (59.5)






25.1 (5.2)* 101 (85.6)
35 (92.1)
GR (16.8), preterm birth (11.9), eclampsia (2.5)
GR (34.2), preterm birth (45.7)
6 (2015) France After diagnosis 52 98 27.0 (7.0) 86 (87.8) GR (5.1), preterm birth (8.2)
16 (2017) China After diagnosis 13 13 29.0 (5.0) 11 (84.6)
GR (15.4 preterm birth (15.4),  













Preeclampsia (4.3), eclampsia (4.3)
18 (2019) Turkey After diagnosis 11 22 31.0 (7.0) 16 (72.7) GR (13.6), preterm birth (18.2)
Present study (N/A) Korea
After diagnosis except  
  for one
7 12 32.0 (12.0) 9 (75.0)
GR (8.3), preterm birth (8.3),  
  preeclampsia (8.3), GDM (16.6)
GR, growth restriction; GDM, gestational diabetes mellitus.
Age at pregnancy are expressed as median (interquartile range) or *mean (standard deviation). 
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cy outcomes in patients with TA, and summarized their find-
ings in Table 4.6,7,14-18 The median maternal age in this study was 
32.0 years, which was higher than the median or mean mater-
nal ages in the previous studies (range: 25.1 to 31.0 years). Al-
though our results are limited by the small sample size of this 
study, it could be explained by the socioeconomic aspect con-
sidering that the mean age of conception was the highest in Ko-
rea among the Organization for Economic Cooperation and 
Development (OECD) nations.19 In this study, the live birth rate 
of all pregnancies was 75%, which was not significantly higher 
than that in previous studies. The highest age at conception of 
Korean patients may partially explain this result. However, it 
may be impossible to directly compare pregnancy morbidities 
between this study and the previous ones, due to varying study 
methods and medical services of different countries. 
Our study had several limitations. The number of pregnan-
cies in this study was too small to represent pregnancy morbidi-
ties in all Korean patients with TA. In particular, the retrospec-
tive design of this study resulted in a small number of available 
pregnancies due to missing data on the pregnancy and deliv-
ery outcomes in a considerable number of patients with TA. 
However, this is this first study to investigate pregnancy mor-
bidities in Korean patients with TA. Since Korea is one of the 
countries with the highest prevalence of TA worldwide, it may 
be meaningful to describe and provide ethnic information on 
pregnancy morbidities in patients with TA in Korea as a pilot 
study. Therefore, a future study with a larger number of patients 
with TA may provide reliable information. In conclusion, the 
live birth rate of Korean patients with TA was 75%. Pregnancy 
morbidities might be associated with the angiographic and 
Ishikawa classifications of TA, but further studies are needed 
for confirmation. Maintaining stable disease during pregnan-
cy might be important to prevent serious maternal complica-
tions or TA progression.
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